Evaluation of risk minimisation activities for cyproterone acetate 2 mg/ethinylestradiol 35 mu g

Davis, K. H., Asiimwe, A., Zografos, L. J., McSorley, D. J., & Andrews, E. (2016). Evaluation of risk minimisation activities for cyproterone acetate 2 mg/ethinylestradiol 35 mu g. Pharmacoepidemiology and Drug Safety, 25(S3), 309-310. https://doi.org/10.1002/pds.4070

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Article

Development of a novel shared decision making aid for primary immunodeficiency diseases
Article

Community overdose surveillance
Article

Epigenetic biomarkers for smoking cessation